Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

PaperCitations, authors & open-access status

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 551 citations, 2014 year and closed oa status.

551
Citations
2014
Year
closed
OA Status

Related on ScholarIQ

Amit M. Oza
Author
Sven Mahner
Author
Nicoletta Colombo
Author
Michael Friedländer
Author
The Lancet Oncology
Journal
PARP inhibition in cancer therapy
Topic
470M+ articles · free account